JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
14 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Issues related to: - Contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - Appropriations for Labor Health and Human Services - NIH funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| DEANA MCRAE | — |
| TIMOTHY SWOPE | — |
| COLLEEN VIVALDI | — |
Consumer Issues/Safety/Products CSP
Issues related to: - Counterfeit healthcare goods - Brand protection
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
Health Issues HCR
- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| DAVID KAVANAUGH | — |
| DEANA MCRAE | — |
| AMY PELLEGRINO | — |
| ABIGAIL PINKELE | — |
| EMELY SANCHEZ | — |
| MEGHAN DRENAN STONE | — |
| WENDY SUSSMAN | — |
| RILEY SWINEHART | — |
| TIMOTHY SWOPE | — |
| COLLEEN VIVALDI | — |
| KELLY WATERS | — |
Labor Issues/Antitrust/Workplace LBR
- Issues related to diversity, equity and inclusion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LARRY CAMM | — |
Veterans VET
- Issues related to Veterans Administration and Veterans Health Administration policy, procurement, and contracting processes for medical technology.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| RILEY SWINEHART | — |
Trade (domestic/foreign) TRD
Issues related to: - Medical supply chains - TRIPS Waiver
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DAVID KAVANAUGH | — |
| WENDY SUSSMAN | — |
| RILEY SWINEHART | — |
| TIMOTHY SWOPE | — |
Science/Technology SCI
S 3312, "Artificial Intelligence Research, Innovation, and Accountability Act", regarding all provisions. Issues related to: - Data privacy - Cybersecurity - Artificial intelligence - Robotics
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
Copyright/Patent/Trademark CPT
- S 150, "Affordable Prescriptions for Patients Act of 2023", regarding all provisions. - S 79/HR 1717, "Interagency Patent Coordination and Improvement Act of 2023", regarding all provisions. - Issues related to intellectual property.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DAVID KAVANAUGH | — |
| TIMOTHY SWOPE | — |
Taxation/Internal Revenue Code TAX
S 866/HR 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing. Issues related to: - OECD proposals on global tax & implementation - R&D expensing - Corporate tax provisions in TCJA - Corporate Alternative Minimum Tax implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DAVID KAVANAUGH | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Pharmacy PHA
- HR 4490, "To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the to the ultimate user, and for other purposes", regarding all provisions. - Issues related to drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY PELLEGRINO | — |
| ABIGAIL PINKELE | — |
| MEGHAN DRENAN STONE | — |
| WENDY SUSSMAN | — |
| TIMOTHY SWOPE | — |
Environment/Superfund ENV
Issues related to - Clean energy - Environmental sustainability Final Rule - U.S. EPA Rulemaking on National Emission Standards for Hazardous Air Pollutants (NESHAP) for Ethylene Oxide.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Bankruptcy BNK
HR 5488, S 2805, "Protecting Our Courts from Foreign Manipulation Act of 2023", regarding provisions relating to transparency from foreign investors in US litigation. Issues related to: - Chapter 11 corporate bankruptcy process - Litigation reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LARRY CAMM | — |
| ABIGAIL PINKELE | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Medicare/Medicaid MMM
Issues related to the Medicaid Drug Rebate Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY PELLEGRINO | — |
| WENDY SUSSMAN | — |
Law Enforcement/Crime/Criminal Justice LAW
- HR 5488 and S 2805, the "Protecting our Courts from Foreign Manipulation Act", regarding all provisions - Issues related to transparency in third-party litigation funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| RILEY SWINEHART | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.